- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07045753
- Original Trial
The Prospective Segeberg Registry for Mitral Transcatheter Edge-to-Edge Repair (SK M-CLIP)
June 22, 2025 updated by: Segeberger Kliniken GmbH
A Prospective Follow-up Assessment in Bad Segeberg With Patients With Severe Mitral Regurgitation Undergoing Mitral Edge-to-edge Repair (M-TEER).
A Prospective Follow-up Assessment in Bad Segeberg for Patients with severe MR undergoing M-TEER
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
A prospective single center registry including all patients treated for severe mitral regurgitation (MR) with mitral edge-to-edge repair (M-TEER) at the Heart Center, Bad Segeberg, Germany.
Patients undergo a routine clinical follow-up schedule, including a long-term follow-up.
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Stephan Fichtlscherer, Prof., MD
- Phone Number: 9915 +4945512802
- Email: Stephan.fichtlscherer@segebergerkliniken.de
Study Contact Backup
- Name: Arief Kurniadi, MD
- Phone Number: 9293 +4945512802
- Email: arief.kurniadi@segebergerkliniken.de
Study Locations
-
-
Schleswig Holstein
-
Bad Segeberg, Schleswig Holstein, Germany, 23795
- Recruiting
- Herzzentrum Segeberger Kliniken GmbH
-
Contact:
- Holger Nef, Prof., MD
- Phone Number: 9890 +4945512802
- Email: holger.nef@me.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with severe MR undergoing M-TEER
Description
Inclusion Criteria:
- Patients with severe MR undergoing M-TEER
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients of severe MR undergoing M-TEER
Patients with severe mitral regurgitation undergoing transcatheter edge to edge repair (M-TEER)
|
mitral valve transcatheter edge-to-edge repair
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of in-hospital and long-term cardiovascular adverse events in percent
Time Frame: 2 years
|
Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death, heart failure, rehospitalization)
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Holger Nef, Prof., MD, Herzzentrum Segeberger Kliniken GmbH
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2011
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2032
Study Registration Dates
First Submitted
June 22, 2025
First Submitted That Met QC Criteria
June 22, 2025
First Posted (Estimated)
July 1, 2025
Study Record Updates
Last Update Posted (Estimated)
July 1, 2025
Last Update Submitted That Met QC Criteria
June 22, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SK 113 - 168/11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mitral Regurgitation (MR)
-
Sun Yat-sen UniversityRecruitingMitral Insufficiency | Mitral Regurgitation (MR)China
-
Intuitive SurgicalNot yet recruiting
-
Mitrassist Lifesciences Limited Co., Ltd.RecruitingMitral Regurgitation (MR)China
-
Artivion Inc.Not yet recruitingMitral Regurgitation (MR)United States, United Kingdom, Italy
-
Beijing HospitalNot yet recruiting
-
China National Center for Cardiovascular DiseasesCompletedPediatric Cardiac Surgery | Mitral Regurgitation (MR)China
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, France; GIRCI IDFNot yet recruiting
-
Centre Hospitalier Universitaire, AmiensRecruitingDegenerative Mitral Regurgitation (MR) Due to Leaflet ProlapseFrance
-
Columbia UniversityAmerican Heart AssociationRecruitingAortic Stenosis | Aortic Regurgitation | Valvular Heart Disease | Valve Disease, Aortic | Tricuspid Regurgitation (TR) | Mitral Regurgitation (MR)United States
-
Abbott Medical DevicesCompletedFunctional Mitral Regurgitation | Degenerrative Mitral RegurgitationRussian Federation
Clinical Trials on Transcatheter edge to edge repair
-
Beijing Anzhen HospitalNot yet recruitingAtrial Functional Mitral RegurgitationChina
-
Robert Bosch Medical CenterRecruitingFrailty | Cardio-Renal Syndrome | Tricuspid Valve Insufficiency | Tricuspid RegurgitationGermany
-
Medical University of WarsawMedical University of Silesia; Poznan University of Medical Sciences; Medical... and other collaboratorsRecruitingHeart Failure | Valve Heart Disease | Tricuspid RegurgitationPoland
-
Barts & The London NHS TrustKing's College Hospital NHS Trust; Royal Brompton & Harefield NHS Foundation... and other collaboratorsNot yet recruiting
-
Istituto Auxologico ItalianoRecruitingTricuspid RegurgitationItaly
-
Abbott Medical DevicesEnrolling by invitationTricuspid Regurgitation (TR)United States, Italy
-
AZ Sint-Jan AVNot yet recruiting
-
Helios Klinikum PforzheimRecruitingRight Heart Failure | Tricuspid Regurgitation | Cardiac Remodeling, Ventricular | Cardiac Remodeling, AtrialGermany
-
LMU KlinikumRecruitingHeart Failure | Valvular Heart Disease | Tricuspid RegurgitationGermany
-
Shanghai Shenqi Medical Technology Co., LtdRecruiting